Sign in
Back
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Journal article   Peer reviewed

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio Vallejo-Vaz, Christophe A.T. Stevens, Alexander R.M. Lyons, Kanika Dharmayat, Tomas Freiberger, G. Kees Hovingh, Pedro Mata, Frederick Raal, Raul Santos, Handrean Soran, …
The Lancet (British edition), Vol.398(10312), pp.1713-1725
06/11/2021
DOI: https://doi.org/10.1016/S0140-6736(21)01122-3
PMID: 34506743

Abstract

Adult Antibodies, Monoclonal, Humanized Anticholesteremic Agents Cholesterol, LDL Coronary Disease Cross-Sectional Studies Europe Female Global Health Heart Disease Risk Factors Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Hyperlipoproteinemia Type II Life Sciences Male Middle Aged Proprotein Convertase 9 Registries Treatment Outcome
The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for the global surveillance of familial hypercholesterolaemia through harmonisation and pooling of multinational data. In this study, we aimed to characterise the adult population with heterozygous familial hypercholesterolaemia and described how it is detected and managed globally.

Metrics

1 Record Views

Details